tacrine has been researched along with arisugacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rashid, ZF; Hsung, RP | 2 |
| Degen, SJ; Golding, GM; Hsung, RP; Mueller, KL; Mulder, JA; Neeno-Eckwall, A; Shen, HC; Wei, LL; Zificsak, CA | 1 |
3 other study(ies) available for tacrine and arisugacin
| Article | Year |
|---|---|
(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
Topics: Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Computer Simulation; Inhibitory Concentration 50; Models, Biological; Models, Molecular; Molecular Structure; Pyrans | 2011 |
A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.
Topics: Acetylcholinesterase; Animals; Binding Sites; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Molecular Docking Simulation; Molecular Structure; Pyrans; Stereoisomerism; Structure-Activity Relationship | 2015 |
Synthesis of dihydroxanthone derivatives and evaluation of their inhibitory activity against acetylcholinesterase: unique structural analogs of tacrine based on the BCD-ring of arisugacin.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Molecular Structure; Pyrans; Tacrine | 1999 |